Billable / Specific Code
ICD-10-CM Z92.850 is the diagnosis code for Personal history of Chimeric Antigen Receptor T-cell therapy. This code falls under the section "Persons with potential health hazards related to family and personal history and certain conditions influencing health status" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where Z92.850 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, Z92.850 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z92.850 is the ICD-10-CM diagnosis code for "Personal history of Chimeric Antigen Receptor T-cell therapy". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of Z92.850 is Z92.85 ("Personal history of cellular therapy"). Z92.850 provides a more specific classification within this category.
Z92.850 is located in Section Z77-Z99 — "Persons with potential health hazards related to family and personal history and certain conditions influencing health status" within Chapter 21 of the ICD-10-CM Tabular List.
Use Z92.850 when the patients documented diagnosis matches "Personal history of Chimeric Antigen Receptor T-cell therapy" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Personal history of Chimeric Antigen Receptor T-cell therapy is Z92.850.
Yes, Z92.850 can be used as a primary diagnosis code since it is billable and specific.
Z92.850 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z92.850 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.